Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribulose-5-phosphate-3-epimerase pseudogene 1 (RPEP1) is a processed pseudogene similar in sequence to the functional ribulose-5-phosphate 3-epimerase gene (RPE). Pseudogenes such as RPEP1 do not encode active proteins and do not serve known biological or pharmacological functions. RPEP1 is thus not considered a therapeutic target. In contrast, the functional ribulose-5-phosphate 3-epimerase (RPE) is a key enzyme in the pentose phosphate pathway and the Calvin cycle, but these functions do not apply to RPEP1 as a pseudogene. RPEP1 is a pseudogene, not an active enzyme or therapeutic target. The actual enzyme with biological function is ribulose-5-phosphate 3-epimerase, encoded by the RPE gene. RPEP1 does not have biological, druggable, or disease-related roles.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribulose-5-phosphate-3-epimerase pseudogene 1 (RPEP1).